WINDTREE THERAPEUTICS INC /DE/ (WINT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 500K 1M 1.5M Q1 '13: 72K Q2 '13: 182K Q3 '13: 60K Q4 '13: 73K Q1 '14: 31K Q2 '14: 1.1M Q3 '14: 527K Q4 '14: 1.2M Q1 '15: 191K Q2 '15: 75K Q3 '15: 66K Q4 '15: 655K Q1 '16: 75K Q2 '16: 106K Q3 '16: 961K Q4 '16: 900K Q1 '17: 219K Q2 '17: 1.1M Q3 '17: 17K Q4 '17: 102K Q1 '18: 204K Q2 '18: 1.1M Q3 '18: 229K Q4 '18: 304K Q1 '19: 40K Q2 '19: 158K Q3 '19: 0 Q4 '19: 0 Q4 '13 Q4 '14 Q4 '15 Q4 '16 Q4 '17 Q4 '18 Q4 '19

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q4 '15: -9.8M Q1 '16: -13.9M Q2 '16: -10M Q3 '16: -7.7M Q4 '16: -6.4M Q1 '17: -8.1M Q2 '17: -6.1M Q3 '17: -4.8M Q4 '17: -3.5M Q1 '18: -4.8M Q2 '18: -3M Q3 '18: -3.5M Q4 '18: -4.9M Q1 '19: -6.7M Q2 '19: -6.5M Q3 '19: -7.2M Q4 '19: -4.6M Q1 '20: -6.7M Q2 '20: -7.9M Q3 '20: -8.7M Q4 '20: -7M Q1 '21: -9.1M Q2 '21: -45.4M Q3 '21: -8.1M Q4 '21: -14.7M Q1 '22: -8.3M Q2 '22: -17.5M Q3 '22: -4.7M Q4 '22: -10.8M Q1 '23: -4.2M Q2 '23: -6.8M Q3 '23: -4.7M Q4 '23: -5M Q1 '24: -4.4M Q2 '24: -11.5M Q3 '24: -4.7M Q4 '24: -5.5M Q1 '25: -4.1M Q2 '25: -4M Q3 '25: -19.9M Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q4 '15: -10.1M Q1 '16: -13.9M Q2 '16: -10.6M Q3 '16: -8.4M Q4 '16: -6.6M Q1 '17: -8.7M Q2 '17: -6.8M Q3 '17: -5.4M Q4 '17: 2.5M Q1 '18: -4.5M Q2 '18: -3.1M Q3 '18: -3.9M Q4 '18: -9M Q1 '19: -6.5M Q2 '19: -6.4M Q3 '19: -7.1M Q4 '19: -7.4M Q1 '20: -6.5M Q2 '20: -9.6M Q3 '20: -9M Q4 '20: -7.5M Q1 '21: -9M Q2 '21: -37.4M Q3 '21: -8.2M Q4 '21: -13.1M Q1 '22: -8.1M Q2 '22: -17.3M Q3 '22: -4.1M Q4 '22: -9.7M Q1 '23: -4.1M Q2 '23: -6.6M Q3 '23: -4.4M Q4 '23: -5.2M Q1 '24: 10.2M Q2 '24: -12M Q3 '24: -2.7M Q4 '24: 2.8M Q1 '25: -4M Q2 '25: -10.6M Q3 '25: -28.1M Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q4 '15: -7.6M Q1 '16: -9.2M Q2 '16: -9.1M Q3 '16: -8.3M Q4 '16: -6.9M Q1 '17: -7.3M Q2 '17: -5.5M Q3 '17: -3.4M Q4 '17: -4.8M Q1 '18: -2.5M Q2 '18: -3.8M Q3 '18: -3.3M Q4 '18: -6.2M Q1 '19: -8.8M Q2 '19: -6.6M Q3 '19: -3.8M Q4 '19: -5.5M Q1 '20: -5.5M Q2 '20: -7M Q3 '20: -8.3M Q4 '20: -4.5M Q1 '21: -6M Q2 '21: -7.4M Q3 '21: -5.3M Q4 '21: -4.9M Q1 '22: -6.7M Q2 '22: -5.3M Q3 '22: -4.1M Q4 '22: -3.4M Q1 '23: -2.5M Q2 '23: -3.5M Q3 '23: -3.9M Q4 '23: -3.6M Q1 '24: -2.9M Q2 '24: -2.3M Q3 '24: -6.4M Q4 '24: -3.7M Q1 '25: -2.4M Q2 '25: -2.7M Q3 '25: -6.4M Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25

Free Cash Flow Quarterly

-12M -8M -4M 0 4M 8M 12M Q1 '13: -10.4M Q2 '13: -10.2M Q3 '13: -10.1M Q4 '13: -10.4M Q1 '14: -10.8M Q2 '14: -10.4M Q3 '14: -11M Q4 '14: -10.2M Q1 '15: -9.1M Q2 '15: -9.7M Q3 '15: -7.5M Q1 '16: -9.3M Q2 '16: -9.1M Q3 '16: -8.4M Q4 '16: -7M Q1 '17: -7.4M Q2 '17: -5.5M Q3 '17: -3.4M Q4 '17: -4.8M Q1 '19: -8.8M Q2 '19: -6.8M Q3 '19: -3.9M Q4 '19: -5.5M Q3 '20: -8.3M Q4 '20: -4.8M Q1 '21: -6M Q2 '21: -7.4M Q3 '21: -5.4M Q4 '21: -5.1M Q1 '22: -6.7M Q2 '22: -5.3M Q3 '22: -4.1M Q4 '22: -3.4M Q1 '23: -2.5M Q2 '23: -3.5M Q3 '23: -3.9M Q4 '23: -3.6M Q3 '24: -6.4M Q4 '24: -3.7M Q3 '25: -6.4M Q1 '14 Q2 '15 Q4 '16 Q1 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 400M 800M 1.2B Q3 '12: 43.4M Q1 '13: 43.7M Q2 '13: 49.9M Q3 '13: 54.8M Q4 '13: 73.1M Q1 '14: 6.1M Q2 '14: 85.9M Q3 '14: 85.2M Q4 '14: 6.1M Q1 '15: 6.1M Q2 '15: 85.8M Q3 '15: 105.7M Q4 '15: 8.1M Q1 '16: 8.2M Q2 '16: 8.2M Q3 '16: 8.4M Q4 '16: 8.5M Q1 '17: 450K Q2 '17: 507K Q3 '17: 729K Q4 '17: 2.5M Q1 '18: 3.2M Q2 '18: 3.8M Q3 '18: 3.8M Q4 '18: 7.2M Q1 '21: 17.7M Q2 '21: 26.4M Q3 '21: 26.7M Q1 '22: 566K Q2 '22: 584K Q3 '22: 623K Q1 '23: 48K Q2 '23: 224K Q3 '23: 286K Q1 '24: 9.3M Q2 '24: 11.5K Q3 '24: 17.7K Q1 '25: 1.1B Q2 '25: 4.9M Q3 '25: 26.7M Q4 '13 Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q2 '22 Q1 '24 Q3 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6000.00 -4000.00 -2000.00 0.00 2000.00 4000.00 6000.00 Q1 '14: -2.56 Q2 '14: -2.48 Q3 '14: -2.39 Q4 '14: -4.33 Q1 '15: -4.33 Q2 '15: -4.32 Q3 '15: -4.39 Q4 '15: -3.55 Q1 '16: -3.29 Q2 '16: -4.45 Q3 '16: -5.25 Q4 '16: -4.76 Q1 '17: -30.46 Q2 '17: -43.54 Q3 '17: -53.07 Q4 '17: -51.33 Q1 '18: -25.33 Q2 '18: -11.77 Q3 '18: -2.28 Q4 '18: -6.49 Q1 '19: -5.70 Q2 '19: -5.49 Q3 '19: -5.11 Q4 '19: -2.08 Q1 '20: -1.95 Q2 '20: -1.98 Q3 '20: -1.86 Q4 '20: -2.08 Q1 '21: -2.11 Q2 '21: -2.90 Q3 '21: -2.67 Q4 '21: -2.66 Q1 '22: -16.51 Q2 '22: -44.77 Q3 '22: -50.97 Q4 '22: -62.84 Q1 '23: -134.13 Q2 '23: -133.92 Q3 '23: -142.88 Q4 '23: -4768.48 Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.